Alkem Laboratories Limited — Updates, 02-06-2026: Press Release
02-06-2026 | 03:13 pm
02-06-2026 | 03:13 pm
Alkem Laboratories launched India's first single-shot pre-filled semaglutide syringes, expanding treatment options for Type 2 diabetes and obesity. This new format, priced from INR350, aims to significantly lower entry barriers for patients.
No comments yet. Be the first to comment!
